To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
This is a protocol.
Denosumab for the treatment and prevention of postmenopausal osteoporosis
You may also be interested in:
- Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
- Calcitonin for preventing and treating corticosteroid-induced osteoporosis
- Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
- Bisphosphonates for treating osteoporosis caused by the use of steroids
- Fluoride can increase bone mineral density at the lumbar spine, it does not reduce vertebral fractures.
Health topics: